A combination of 10 blood proteins distinguished people with amyotrophic lateral sclerosis (ALS) from healthy people with 98.3% balanced accuracy in a new study. “This 10-protein combination in our ALS disease prediction model classified ALS vs control with superior accuracy … to previously published studies,” researchers wrote. However, the…
News
Two interconnected themes — community and hope — dominated the conversations at a recent gathering of people living with neuromuscular diseases. Lily Sander, MDA National Ambassador, speaking at MDA Engage: Dallas. (Photo by Tara Haelle) Lily Sander, national ambassador for the Muscular Dystrophy Association (MDA), hit on those…
A history of head injury is associated with 36% higher odds of amyotrophic lateral sclerosis (ALS), according to a systematic review and meta-analysis of 29 studies involving more than 5 million people. The review included 22 studies that compared people with and without ALS, looking at…
AP-101, an experimental treatment being developed by AL-S Pharma for amyotrophic lateral sclerosis (ALS), may help patients preserve their body weight compared with a placebo, potentially indicating better clinical outcomes as the disease progresses. These findings come from a post-hoc analysis of AP101-02 (NCT05039099), a completed Phase…
ALS.Community has launched a new free online platform to help people with amyotrophic lateral sclerosis (ALS), their families, and caregivers connect with others, share experiences, and find practical support. Developed with input from people living with ALS, the patient-led nonprofit platform offers discussion communities, virtual events, educational…
Combining spinal fluid biomarkers associated with Alzheimer’s disease with levels of neurofilament light chain (NfL), a biomarker of nerve damage, may improve the diagnosis of people with amyotrophic lateral sclerosis (ALS) and predict their long-term outcomes, a study suggests. For example, people with ALS who test positive for the…
Scientists have been searching for a cure for amyotrophic lateral sclerosis (ALS) for more than a century, and they are making faster progress than ever before in today’s collaborative research environment, according to Daragh Heitzman, MD, director of the ALS Clinic at Texas Neurology in Dallas. Heitzman, who…
Tongue exercise may help surviving nerve cells compensate for damage associated with amyotrophic lateral sclerosis (ALS), a new study in rats suggests. Nicole Nichols, PhD, the study’s senior author at the University of Missouri, said the findings may lead to treatments that help preserve tongue function in people with…
In amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene, a protein called S100A6 may contribute to the buildup of toxic protein clumps by interfering with their removal, a study in mouse and cell models suggests. Researchers found increased expression of the S100a6 gene in mouse models…
Blood tests measuring levels of neurofilament light chain (NfL), a biomarker of nerve damage, may help identify people who eventually develop amyotrophic lateral sclerosis (ALS) more than a decade in advance, according to a new study. Elevated levels of NfL — a protein that provides structural support…
Recent Posts
- Blood protein panel may offer new way to identify ALS, researchers report
- MDA Engage: Event sessions highlight community, hope
- Head injuries linked to higher odds of ALS in large research review
- Experimental treatment may help preserve body weight in ALS, data show
- ALS doesn’t have a cure, but compassion helps